Back to today’s briefing

Story perspectives

GLP-1 Drugs: Weight Loss, Diabetes Relief, and More!

11/20/2025

30 5 Full Breakdown

Summary

Story summary

A World Health Organization review shows GLP-1 drugs like Ozempic and Mounjaro lead to meaningful weight loss.
The FDA has approved GLP-1s for type 2 diabetes and obesity.
Emerging research suggests GLP-1s may lower risks of Alzheimer's disease and certain cancers.
Access and affordability have improved recently as costs decrease globally.

1 of 1

Story summary

A World Health Organization review shows GLP-1 drugs like Ozempic and Mounjaro lead to meaningful weight loss.
The FDA has approved GLP-1s for type 2 diabetes and obesity.
Emerging research suggests GLP-1s may lower risks of Alzheimer's disease and certain cancers.
Access and affordability have improved recently as costs decrease globally.